Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01384240 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of a Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia
A Early Phase 1 study, sponsored by Anandasabapathy, Sharmila, M.D..
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 183
- Enrollment target
NCT01384240 is a Early Phase 1 study that was terminated before completion, run by Anandasabapathy, Sharmila, M.D.. The registered enrollment target is 183 participants.
The verdict
NCT01384240, a Early Phase 1 study, was terminated before completion, sponsored by Anandasabapathy, Sharmila, M.D..
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 183 participants
- Enrollment target
Study Summary
The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of the colon can assist clinicians in detecting dysplastic (precancerous) and neoplastic areas. This is a pilot study of a novel technology, a miniaturized microscope device which can be used during standard endoscopy to image the gastrointestinal epithelium. Theoretically, by visualizing superficial mucosal changes at a high-resolution and magnification, the investigators will be able to obtain optical images that can be used to guide endoscopic biopsy and polypectomy. This may foster the selective targeting of dysplasia/neoplasia, thereby improving diagnostic accuracy.
Interventions
- DRUG Proflavine Hemisulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2010-04 |
| Est. Completion | 2014-05 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01384240
The ClinicalTrials.gov registry entry for NCT01384240 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anandasabapathy, Sharmila, M.D., which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proflavine Hemisulfate is the first listed.
NCT01384240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01384240 about?
NCT01384240 is a clinical study titled "Evaluation of a Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia". The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of the colon can assist clinicians in detecting dysplastic (precancerous) and neoplastic areas. This is a pilot study of a novel technology, a miniaturized microscope device which can be used during sta...
What is the current status of trial NCT01384240?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 183 participants. The study started on 2010-04. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01384240?
The interventions under investigation include: Proflavine Hemisulfate (DRUG).
Who is sponsoring clinical trial NCT01384240?
This trial is sponsored by Anandasabapathy, Sharmila, M.D., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.